CMLD-2

CAS No. 958843-91-9

CMLD-2( —— )

Catalog No. M34849 CAS No. 958843-91-9

CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 258 In Stock
5MG 235 In Stock
10MG 392 In Stock
25MG 642 In Stock
50MG 877 In Stock
100MG 1181 In Stock
200MG Get Quote In Stock
500MG 2353 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CMLD-2
  • Note
    Research use only, not for human use.
  • Brief Description
    CMLD-2 is an inhibitor of HuR-ARE interaction (Ki: 350 nM) that competitively binds HuR protein and disrupts its interaction with adenine element-rich (ARE) mRNA targets.
  • Description
    CMLD-2, an inhibitor of HuR-ARE interaction, competitively binds HuR protein disrupting its interaction with adenine-uridine rich elements (ARE)-containing mRNAs (Ki=350 nM). CMLD-2 induces apoptosis exhibits antitumor activity in different cancer cells as colon, pancreatic, thyroid and lung cancer cell lines. Hu antigen R (HuR) is an RNA binding protein, can regulate target mRNAs stability and translation.
  • In Vitro
    Cell Viability Assay Cell Line:SW1736, 8505C, BCPAP and K1 cells Concentration:1, 5, 10, 25, 35, 50, 75 μM Incubation Time:24, 48, 72 hours Result:Reduced the viability of all the four cell lines when used at 35, 50 and 75?μM concentration and at different time points.Apoptosis AnalysisCell Line:H1299, A549, H1975, HCC827, MRC-9 and CCD16 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Marked activated the caspase-9 and -3 in lung tumor cells.Induce the cleavage of PARP in lung tumor cells.Significantly increased the annexin-V-positive staining in lung tumor cells.Cell Cycle Analysis Cell Line:H1299, A549, MRC-9 and CCD16 cells Concentration:30 μM Incubation Time:24, 48 hours Result:Induced greater G1 phase cell cycle arrest in H1299 and A549 cells than in MRC-9 and CCD16 cells.Western Blot Analysis Cell Line:H1299, A549, H1975, HCC827, CCD16 and MRC-9 cells Concentration:20, 30 μM Incubation Time:24, 48 hours Result:Diminished protein expression of HuR, Bcl-2, Cyclin E and Bcl-XL and increased expression of p27 and BAX in lung tumor cells.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis | HuR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    958843-91-9
  • Formula Weight
    513.58
  • Molecular Formula
    C31H31NO6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (97.36 mM; Ultrasonic )
  • SMILES
    COc1ccc(cc1)C(CC(=O)N1CCCC1)c1c(OC)cc(OC)c2c(cc(=O)oc12)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wu X, et, al. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction. ACS Chem Biol. 2015 Jun 19;10(6):1476-84.?
molnova catalog
related products
  • CP 461

    CP 461 (UNII-68OJX9I7DT), a specific PDE2A inhibitor, is a novel pro-apoptotic compound that inhibits cyclic GMP phosphodiesterase but not cyclooxygenase-1 or -2.

  • CTA 056

    CTA 056 is an interleukin-2 induced T cell kinase (ITK) inhibitor, inhibits the growth of MOLT-4 xenograft tumors in mice, induces apoptosis in Jurkat cells, and can be used in the study of autoimmune disorders and T cell malignancies.

  • Exisulind

    Exisulind induces apoptosis through the activation of protein kinase G (PKG). Exisulind exhibits antineoplastic activity in solid tumour and haematological cancer cell lines and is an inhibitor of tumour growth in rodent models of colon, prostate, bladder, mammary and lung cancer.